- Home
- JMSB vs HUMA Comparison
JMSB vs HUMA Comparison
Compare JMSB & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JMSB
- HUMA
- Stock Information
- Founded
- JMSB 2005
- HUMA 2004
- Country
- JMSB United States
- HUMA United States
- Employees
- JMSB 133
- HUMA N/A
- Industry
- JMSB Major Banks
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- JMSB Finance
- HUMA Health Care
- Exchange
- JMSB Nasdaq
- HUMA Nasdaq
- Market Cap
- JMSB 250.6M
- HUMA 221.8M
- IPO Year
- JMSB N/A
- HUMA N/A
- Fundamental
- Price
- JMSB $17.44
- HUMA $2.67
- Analyst Decision
- JMSB
- HUMA Strong Buy
- Analyst Count
- JMSB 0
- HUMA 7
- Target Price
- JMSB N/A
- HUMA $13.00
- AVG Volume (30 Days)
- JMSB 16.4K
- HUMA 5.4M
- Earning Date
- JMSB 07-23-2025
- HUMA 05-13-2025
- Dividend Yield
- JMSB 2.87%
- HUMA N/A
- EPS Growth
- JMSB 475.76
- HUMA N/A
- EPS
- JMSB 1.24
- HUMA N/A
- Revenue
- JMSB $54,782,000.00
- HUMA $517,000.00
- Revenue This Year
- JMSB N/A
- HUMA N/A
- Revenue Next Year
- JMSB N/A
- HUMA $896.45
- P/E Ratio
- JMSB $14.07
- HUMA N/A
- Revenue Growth
- JMSB 50.81
- HUMA N/A
- 52 Week Low
- JMSB $13.81
- HUMA $1.15
- 52 Week High
- JMSB $26.52
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- JMSB 56.02
- HUMA 69.67
- Support Level
- JMSB $17.01
- HUMA $2.41
- Resistance Level
- JMSB $17.68
- HUMA $2.88
- Average True Range (ATR)
- JMSB 0.42
- HUMA 0.30
- MACD
- JMSB -0.05
- HUMA 0.10
- Stochastic Oscillator
- JMSB 40.76
- HUMA 87.43
About JMSB John Marshall Bancorp Inc.
John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.